News | TCT | July 12, 2022

CRF and Fogarty Innovation Launch the “TCT MedTech Innovation Forum”

A multi-disciplinary group of MedTech stakeholders will convene just before the main sessions of TCT 2022 to provide real-world insight into health technology advancements, challenges and opportunities

A Multi-Disciplinary Group of MedTech Stakeholders Will Convene Just Before the Main Sessions of TCT 2022 to Provide Real-World Insight into Health Technology Advancements, Challenges, and Opportunities

Getty Images


July 12, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that they are joining forces to launch the "TCT MedTech Innovation Forum” just before the main sessions of TCT (Transcatheter Cardiovascular Therapeutics) 2022, the annual scientific symposium of CRF. TCT will be held September 16-19, 2022, in Boston, Massachusetts at the Boston Convention and Exhibition Center. 

The TCT MedTech Innovation Forum is an intensive interactive summit bringing together clinicians, entrepreneurs, investors, payors, and regulators to identify clinical challenges, uncover opportunities for innovation, and drive a practical understanding of the rewards and complex process required to bring novel medical technologies to market. The intent is to shape the future of patient care and MedTech innovation through informed discussion, debate, and real-world insight. 

“We’re thrilled to partner with Fogarty Innovation to create a world-class forum with the goal of inspiring and driving innovation forward to improve the quality, accessibility, and cost of delivering cardiovascular care,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF. “We’re committed to bringing the latest medical breakthroughs to physicians and their patients as quickly as possible. This forum will convene like-minded individuals with a collective vision, passion, and purpose in a stimulating environment that fosters networking, promotes collaborations, and sparks novel ideas which are essential to driving innovation and improving healthcare.” 

“TCT is the premier gathering for practitioners and researchers in interventional cardiovascular medicine,” said Andrew Cleeland, Chief Executive Officer of Fogarty Innovation. “Bringing these clinicians together with stakeholders from across the ecosystem is critical to advancing MedTech innovation. In keeping with Fogarty Innovation’s mission, we anticipate facilitating collaborations to foster novel solutions which will transform care for patients everywhere.” 

The Forum will offer multiple formats for audience engagement. Presenters and panel discussants will share interdisciplinary perspectives and evaluate emerging trends in MedTech innovation, encompassing digital health, health policy and equity, clinical challenges, financing, regulatory and reimbursement policy, and evolving healthcare delivery models.a  

Attendance is open to all in-person TCT registrants. To learn more, visit https://tct2022.crfconnect.com/register. 


Additional Content

News | Cardiovascular Education

Oct. 12, 2026 — The American Heart Association has expanded its education portfolio to help clinicians put the new ...

Home October 12, 2026
Home
News | Cardiovascular Education

March 31, 2026 — The global community of heart rhythm specialists will unite in Paris, April 12-14, 2026, for EHRA 2026 ...

Home April 01, 2026
Home
News | Cardiovascular Education

Feb. 14, 2026 — Cardiovascular Research Foundation (CRF) has announced the creation of Complex Coronary Summit, a new ...

Home February 19, 2026
Home
News | Cardiovascular Education

Feb. 3, 2026 — The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI ...

Home February 04, 2026
Home
News | Cardiovascular Education

Nov. 12, 2025 — The Association of Black Cardiologists (ABC) has released new findings from a national survey exposing a ...

Home November 17, 2025
Home
Subscribe Now